If you've started taking a GLP-1 medication like Ozempic, Wegovy, or Mounjaro — or you're thinking about it — there's a dental side effect that's now on the radar of clinicians across Australia, and it moves faster than most people expect.
Dentists have started calling it "Ozempic teeth." This article explains what's actually happening in your mouth, why some patients experience rapid deterioration while others don't, and why a set of Japanese dental products — including one specifically recommended by the Japan Dental Association — addresses the problem in a way that general oral care advice simply doesn't.
What Is "Ozempic Teeth"?
"Ozempic teeth" isn't an official diagnosis. It's a phrase that emerged as dentists began noticing a pattern: patients on GLP-1 medications presenting with sudden, unexpected tooth decay, sensitivity, and in some cases tooth loss — despite previously healthy dental records.
The medications themselves — semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — don't directly dissolve enamel. The damage is indirect, and it works through three connected pathways.
Reduced saliva production
GLP-1 receptor agonists affect the salivary glands and reduce thirst signalling. You produce less saliva and drink less water. Saliva is the mouth's primary defence — it neutralises acid, delivers minerals to repair enamel continuously throughout the day, and washes away bacteria. When that flow drops, the protection disappears.
Nausea and vomiting
A well-documented side effect, particularly in the early months of use. Stomach acid reaching the mouth repeatedly is highly erosive to enamel. Even infrequent reflux can accelerate erosion significantly over time.
Reduced eating frequency
Less chewing means less saliva stimulation. People on GLP-1 medications often eat far less frequently, removing a key natural trigger for saliva production throughout the day.
These three factors combine to create conditions where enamel is under sustained acid challenge with a reduced capacity to recover. People who have never had a cavity can develop several within six months of starting the medication. The speed of the change is what's putting this on every dentist's radar — and what makes early action worth taking.
Why Japan's Approach to This Problem Is Different
Japan has a long tradition of preventive dentistry that goes well beyond what Western oral care routines typically include. Rather than waiting for decay and then restoring it, Japanese dental practice emphasises daily active protection — particularly through functional foods and chewing gum that deliver minerals to tooth surfaces throughout the day, not just during brushing.
This approach isn't incidental. Japan's dental community has long recognised that the mouth is under continuous chemical challenge, and that passive hygiene isn't enough in high-risk conditions. Reduced saliva — whether from medication, ageing, illness, or lifestyle — is one of those conditions, and Japanese dental products have been formulated specifically to address it.
Two of the products BreezeCare carries reflect this philosophy directly. Both are formulated in Japan. One carries a formal recommendation from the Japan Dental Association.
Recaldent Gum — Recommended by the Japan Dental Association
Recaldent chewing gum carries the official recommendation of the Japan Dental Association, recognising it as a product that supports tooth remineralisation and enhances the acid resistance of teeth.
The active ingredient is CPP-ACP — Casein Phosphopeptide-Amorphous Calcium Phosphate — a bioactive compound derived from milk protein that binds to tooth surfaces and biofilm, and releases calcium and phosphate ions on demand when the mouth's pH drops under acid challenge. It effectively acts as a portable mineral delivery system for your enamel, supplying what reduced saliva can no longer provide.
The mechanism is directly matched to what GLP-1 medications do to the mouth. When saliva flow drops, the mouth loses its natural supply of the minerals that continuously repair microscopic enamel damage. Recaldent compensates for that loss at the tooth surface itself — not systemically, not after the fact, but in real time, throughout the day.
Multiple clinical studies support CPP-ACP's role in reducing enamel demineralisation and supporting remineralisation, particularly under conditions of reduced saliva. The chewing action itself adds a second layer of benefit, mechanically stimulating whatever saliva production remains.
BreezeCare carries Recaldent PLUS Gum in Mint and Grape — the most concentrated CPP-ACP formulation — and the Recaldent Original Gum range across multiple flavours including Blood Orange, Mint and Grape. Both are sugar-free. For GLP-1 users, chewing after each meal or eating occasion — even a small one — is when the protection matters most.
PosCaF Gum — Japanese Enamel Protection with FOSHU Approval
PosCaF is a Japanese functional chewing gum containing POs-Ca technology developed by Glico, combining calcium and phosphate in a bioavailable form designed to support enamel remineralisation. Products containing POs-Ca have received FOSHU (Foods for Specified Health Uses) approval in Japan — a government-level designation granted only to products that have demonstrated a specific, substantiated health benefit through clinical evidence. In Japan's regulatory framework, FOSHU approval is one of the highest standards a functional food can meet.
The formulation takes a complementary approach to Recaldent — where Recaldent's CPP-ACP system binds to tooth surfaces and releases minerals under acid challenge, POs-Ca delivers bioavailable calcium and phosphate to support enamel repair through a different pathway. For people at elevated dental risk — which anyone on a GLP-1 medication now is — using both products as part of a daily routine provides broader coverage.
PosCaF is not widely available outside Japan. BreezeCare is one of the few sources in Australia.
The Broader Japanese Oral Care Collection
Recaldent and PosCaF sit within a wider Japanese oral care collection at BreezeCare that reflects the same preventive philosophy.
Oral Peace Toothpaste is a Japanese formulation developed with attention to the oral microbiome — designed to support a balanced bacterial environment rather than simply eliminating bacteria indiscriminately. For people on GLP-1 medications whose oral environment is already disrupted, this approach to daily brushing is well suited.
Breo EX Oral Tablets are a chewable oral care tablet used widely in Japan, supporting fresh breath and oral hygiene through use between meals — particularly relevant for GLP-1 users who eat less frequently and have fewer natural saliva triggers across the day.
Flossy Kids Floss Picks bring the same Japanese quality standards to children's daily routines.
The collection isn't assembled around a trend. It reflects the way Japanese dentistry has approached preventive oral care for decades — with products designed for daily use, formulated to active functional standards, and tested through clinical and institutional research. For someone managing the oral changes that come with GLP-1 medication, that foundation is exactly what's needed.
A Practical Daily Protocol for GLP-1 Users
The goal is to keep your mouth in a neutral or remineralising state as much as possible throughout the day, compensating for the saliva you're no longer producing in the same volume.
After each meal or eating occasion — even a small one — chew Recaldent PLUS Gum for 15 to 20 minutes. This delivers CPP-ACP to tooth surfaces at the precise moment they're under acid challenge, while mechanically stimulating saliva production.
If you experience nausea or vomiting, rinse with water immediately and wait at least 30 minutes before brushing. Brushing softened enamel after acid exposure accelerates erosion rather than preventing it.
Brush twice daily with a remineralising toothpaste. Oral Peace Toothpaste is a considered choice given its formulation philosophy and microbiome-aware approach.
Consider adding PosCaF gum at a different point in the day to your Recaldent routine — the two products work through complementary mechanisms and are designed for regular daily use.
Stay hydrated deliberately. The reduced thirst signalling caused by GLP-1 medications means you need to drink water on a schedule, not just when you feel thirsty.
Tell your dentist you're on a GLP-1 medication. They can increase check-up frequency and monitor enamel changes while they're still manageable.
Act Before the Damage Appears
One characteristic of GLP-1-related dental deterioration that dentists are flagging is its speed. Unlike typical decay, which develops gradually over years, patients with significantly reduced saliva flow can experience rapid enamel loss in months. Enamel doesn't regenerate. Once it's gone, the options are restorative — fillings, crowns — not reversible.
The products and protocols above don't eliminate risk entirely. Nothing replaces adequate saliva and regular professional care. But the science behind CPP-ACP is well established, the Japan Dental Association's recommendation of Recaldent reflects decades of clinical use in Japan, and the products are available without a prescription and can be started today.
Japan's dental community built its preventive philosophy around a simple premise: the mouth needs daily active support, not just twice-daily brushing. For anyone on a GLP-1 medication, that premise has never been more directly relevant.
Browse the full Recaldent range, PosCaF Gum, and the Japanese Oral Care collection at BreezeCare.
This content is general education only and is not individual medical or dental advice. Always read the label and follow directions for use. If symptoms persist, consult your healthcare professional. Products containing CPP-ACP (Recaldent) are not suitable for people with a milk protein allergy.
